Biotechnology Market to Reach $4.5 Trillion by 2035
Biotechnology market is expected to witness remarkable growth through 2035, driven by increasing investments in biopharmaceutical research, rising demand for personalized medicine, and rapid advancements in gene editing and cell therapy technologies. Growing adoption of recombinant DNA technology, monoclonal antibody technology, tissue engineering, and fermentation technology across healthcare and industrial applications is accelerating market expansion globally. Additionally, the rising prevalence of chronic diseases, increasing vaccine development activities, and expanding research collaborations among pharmaceutical companies, research institutes, and contract research organizations are further supporting market growth.
Browse the full report description of “Biotechnology Market Size, Share & Trends Analysis Report, By Product Type (Biopharmaceuticals, Biosimilars, Vaccines, Cell & Gene Therapy Products, Industrial Biotech Products, Research & Diagnostic Reagents), By Technology Type (Recombinant DNA Technology, Monoclonal Antibody Technology, Cell Therapy Technology, Gene Editing Technology, Fermentation Technology, Tissue Engineering), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Diagnostic Laboratories), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/biotechnology-market
Illumina Expands Genomics and Bioinformatics Capabilities with DRAGEN Software Enhancements (2025)
Illumina, Inc. expanded its genomics and bioinformatics ecosystem through upgrades to its DRAGEN™ secondary analysis software and multiomics analysis platforms in 2025. The enhancements are designed to support precision medicine, clinical genomics, AI-enabled sequencing analysis, oncology biomarker research, and biotechnology R&D applications. The development strengthens the company’s position in genomic medicine and molecular diagnostics while supporting the growing adoption of advanced biotechnology solutions across healthcare and research sectors.
Thermo Fisher Scientific Strengthens Biologics Manufacturing Portfolio Through Solventum Acquisition Agreement (2025)
Thermo Fisher Scientific Inc. announced an agreement to acquire Solventum’s Purification & Filtration business in 2025 to expand its bioprocessing and biologics manufacturing capabilities. The acquisition enhances the company’s portfolio across biologics production technologies, cell culture processing, biopharmaceutical filtration, downstream bioprocessing, and biotechnology manufacturing solutions. The development reflects increasing global investments in biologics production infrastructure and advanced biotechnology manufacturing technologies.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404